Elevated Serotonin 1A Binding in Remitted Major Depressive Disorder: Evidence for a Trait Biological Abnormality

[1]  S Kasper,et al.  Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders , 2009, Molecular Psychiatry.

[2]  P. Albert,et al.  Transcriptional regulation at a HTR1A polymorphism associated with mental illness , 2008, Neuropharmacology.

[3]  R Todd Ogden,et al.  Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. , 2008, Journal of psychiatric research.

[4]  J. Oehler,et al.  Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice. , 2008, European journal of pharmacology.

[5]  D. Nutt,et al.  Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. , 2008, The British journal of psychiatry : the journal of mental science.

[6]  Juha Markkula,et al.  Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. , 2008, The international journal of neuropsychopharmacology.

[7]  M. Boldrini,et al.  Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. , 2008, Journal of psychiatric research.

[8]  B. Hanusa,et al.  Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. , 2008, Fertility and sterility.

[9]  D. Kupfer,et al.  Serotonin-1A receptor imaging in recurrent depression: replication and literature review. , 2007, Nuclear medicine and biology.

[10]  P. Cowen,et al.  ‘It's not over when it's over’: persistent neurobiological abnormalities in recovered depressed patients , 2007, Psychological Medicine.

[11]  G. Escolar,et al.  Hormonal response to buspirone is not impaired in major depression , 2007, Human psychopharmacology.

[12]  D. Kupfer,et al.  Measurement of 5‐HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY‐100635 , 2007, Synapse.

[13]  Wolfgang Wadsak,et al.  Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder , 2007, Biological Psychiatry.

[14]  David Goldman,et al.  Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. , 2007, Archives of general psychiatry.

[15]  Gavin P. Reynolds,et al.  Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT2A receptor binding in the rat , 2007, Psychopharmacology.

[16]  A. Gjedde,et al.  Parametric and Regional Maps of Free Serotonin 5HT1A Receptor Sites in Human Brain as Function of Age in Healthy Humans , 2007, Neuropsychopharmacology.

[17]  A. Schene,et al.  Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies , 2007, Molecular Psychiatry.

[18]  David P. Friedman,et al.  Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys. , 2006, Archives of general psychiatry.

[19]  Ramin V. Parsey,et al.  Altered Serotonin 1A Binding in Major Depression: A [carbonyl-C-11]WAY100635 Positron Emission Tomography Study , 2006, Biological Psychiatry.

[20]  R Todd Ogden,et al.  Higher 5-HT1A Receptor Binding Potential During a Major Depressive Episode Predicts Poor Treatment Response: Preliminary Data from a Naturalistic Study , 2006, Neuropsychopharmacology.

[21]  J. Mann,et al.  Brain Serotonin1A Receptor Binding in Major Depression Is Related to Psychic and Somatic Anxiety , 2005, Biological Psychiatry.

[22]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[23]  Victoria Arango,et al.  Regional Heterogeneity of 5-HT1A Receptors in Human Cerebellum as Assessed by Positron Emission Tomography , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  R Todd Ogden,et al.  Estimation in regression models with externally estimated parameters. , 2005, Biostatistics.

[25]  Michael G Stabin,et al.  Biodistribution and radiation dosimetry of 11C-WAY100,635 in humans. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  Sati Mazumdar,et al.  Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression , 2004, Neuropsychopharmacology.

[27]  P A Sargent,et al.  Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635 , 2004, Molecular Psychiatry.

[28]  Peter Herscovitch,et al.  Reduced Serotonin Type 1A Receptor Binding in Panic Disorder , 2004, The Journal of Neuroscience.

[29]  Philippe Courtet,et al.  Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts , 2003, Biological Psychiatry.

[30]  Gustavo Turecki,et al.  Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide , 2003, The Journal of Neuroscience.

[31]  C. Stockmeier.  Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. , 2003, Journal of psychiatric research.

[32]  D. Ciraulo.  Neuropsychopharmacology: The Fifth Generation of Progress , 2003 .

[33]  Victoria Arango,et al.  Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635 , 2002, Brain Research.

[34]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[35]  P. Cowen,et al.  State and trait abnormalities in serotonin function in major depression. , 2002, The British journal of psychiatry : the journal of mental science.

[36]  F. Turkheimer,et al.  5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochlori , 2002, The Journal of pharmacology and experimental therapeutics.

[37]  L. Naudon,et al.  A chronic treatment with fluoxetine decreases 5-HT1A receptors labeling in mice selected as a genetic model of helplessness , 2002, Brain Research.

[38]  Roger N. Gunn,et al.  A Database of [11C]WAY-100635 Binding to 5-HT1A Receptors in Normal Male Volunteers: Normative Data and Relationship to Methodological, Demographic, Physiological, and Behavioral Variables , 2002, NeuroImage.

[39]  Daniel J Buysse,et al.  Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: II. comparison during remission , 2002, Biological Psychiatry.

[40]  M Slifstein,et al.  Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. , 2001, Nuclear medicine and biology.

[41]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[42]  Shitij Kapur,et al.  Serotonin 5-HT1A Receptor Binding Potential Declines with Age as Measured by [11C]WAY-100635 and PET , 2001, Neuropsychopharmacology.

[43]  Chester A. Mathis,et al.  Gender-specific aging effects on the serotonin 1A receptor , 2001, Brain Research.

[44]  陳進明,et al.  Serotonin , 2001 .

[45]  M Slifstein,et al.  Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  M Slifstein,et al.  Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions. , 2000, Nuclear medicine and biology.

[47]  P A Sargent,et al.  Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.

[48]  D. Kupfer,et al.  Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.

[49]  R. Bornstein,et al.  Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task. , 1999, Neuropsychology.

[50]  J. Flory,et al.  Recovery from Major Depression Is Not Associated with Normalization of Serotonergic Function , 1998, Biological Psychiatry.

[51]  G Brix,et al.  Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  Allan L. Reiss,et al.  Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome , 1997, Psychiatry Research: Neuroimaging.

[53]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[54]  Daniel J Buysse,et al.  Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I. Comparison during acute depressive states , 1995, Biological Psychiatry.

[55]  P B Hoffer,et al.  Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[56]  W. Bank.  The Human Brain. Surface, Three-Dimensional Sectional Anatomy and MRI , 1993 .

[57]  G. Burrows.  Long-term treatments of recurrent depressive disorders. , 1992 .

[58]  D. Kupfer,et al.  EEG sleep profiles and recurrent depression , 1991, Biological Psychiatry.

[59]  E. Cabanis,et al.  The Human Brain: Surface, Three-Dimensional Sectional Anatomy and Mri , 1991 .

[60]  J. Talairach,et al.  Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .

[61]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[62]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.

[63]  D Lester,et al.  The measurement of pessimism: the hopelessness scale. , 1974, Journal of consulting and clinical psychology.

[64]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[65]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[66]  R Todd Ogden,et al.  Lower serotonin transporter binding potential in the human brain during major depressive episodes. , 2006, The American journal of psychiatry.

[67]  David Goldman,et al.  Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. , 2006, The American journal of psychiatry.

[68]  B. Lebowitz,et al.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.

[69]  Dennis S. Charney,et al.  Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .

[70]  J. Ashburner,et al.  Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.

[71]  T Sandor,et al.  An interactive procedure for extracting features of the brain from magnetic resonance images: The lobes , 1997, Human brain mapping.

[72]  D. Newport,et al.  A Single Scatter Simulation Technique for Scatter Correction in 3D PET , 1996 .

[73]  M. Thase.  Long-term treatments of recurrent depressive disorders. , 1992, The Journal of clinical psychiatry.

[74]  Andrew P. Smith,et al.  State and trait , 1992 .